Anna Papadopoulou

Dr. Anna Papadopoulou


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 September 2015 in Multidisciplinary Respiratory Medicine
Verified
Journal Article
Open access
PDF file
APAnna Papadopoulou
Anna Papadopoulou
PKPanayiotis Kouis
Panayiotis Kouis
NMNicos Middleton
Nicos Middleton
OKOurania Kolokotroni
Ourania Kolokotroni
TKThemistokles Karpathios
Themistokles Karpathios
PYPANAYIOTIS YIALLOUROS
PANAYIOTIS YIALLOUROS
Polymorphisms in the vitamin D receptor (VDR) gene have been studied in immune-related disorders either as independent contributors or in combination with vitamin D concentration. Vitamin D and VDR have been independently linked to asthma susceptibility. We investigated whether VDR variants were associated independently or in relation to vitamin D levels with asthma in Cypriot adolescents. We studied 190 current wheezers, 69 of which were categorized as active asthmatics and 671 healthy controls. We determined three VDR genotypes (BsmI, TaqI, ApaI) and measured serum 25(OH)D levels. Logistic regression and stratified analyses by the presence of hypovitaminosis D (≤20 ng/ml) were used to evaluate the association of the VDR variants with asthma. The distribution of TaqI genotypes was significantly different between controls and current wheezers (p = 0.030) or active asthmatics (p = 0.014). The tt genotype was over-represented in wheezers (19.2 %) and asthmatics (21.3 %) compared to respective controls (12.9 %). No difference was observed between controls, current wheezers and active asthmatics in the genotypic distribution of BsmI and ApaI polymorphic sites. After stratification by the presence of hypovitaminosis D, a significant association was detected between tt genotype of TaqI polymorphism with wheezing (OR: 1.97, 95 % CI: 1.12, 3.46) and asthma (OR: 2.37, 95CI%: 1.02, 5.52) only in those with normal vitamin D levels (>20 ng/ml) but not in subjects with low vitamin D. The minor TaqI genotype of VDR is associated with asthma in Cypriot adolescents. This polymorphism may contribute to asthma susceptibility primarily under conditions of normal vitamin D levels (>20 ng/ml).

13 May 2021 in Genes
Verified
Journal Article
Open access
PDF file
APAnna Papadopoulou
Anna Papadopoulou
EBEVANGELIA BOUNOUVI
EVANGELIA BOUNOUVI
FKFotini-Heleni Karachaliou
Fotini-Heleni Karachaliou
Calcium (Ca) and Phosphorus (P) hold a leading part in many skeletal and extra-skeletal biological processes. Their tight normal range in serum mirrors their critical role in human well-being. The signalling “voyage” starts at Calcium Sensing Receptor (CaSR) localized on the surface of the parathyroid glands, which captures the “oscillations” of extracellular ionized Ca and transfers the signal downstream. Parathyroid hormone (PTH), Vitamin D, Fibroblast Growth Factor (FGF23) and other receptors or ion-transporters, work synergistically and establish a highly regulated signalling circuit between the bone, kidneys, and intestine to ensure the maintenance of Ca and P homeostasis. Any deviation from this well-orchestrated scheme may result in mild or severe pathologies expressed by biochemical and/or clinical features. Inherited disorders of Ca and P metabolism are rare. However, delayed diagnosis or misdiagnosis may cost patient’s quality of life or even life expectancy. Unravelling the thread of the molecular pathways involving Ca and P signaling, we can better understand the link between genetic alterations and biochemical and/or clinical phenotypes and help in diagnosis and early therapeutic intervention.

31 January 2015 in BMC Public Health
Verified
Journal Article
Open access
PDF file
OKOurania Kolokotroni
Ourania Kolokotroni
APAnna Papadopoulou
Anna Papadopoulou
NMNicos Middleton
Nicos Middleton
CKChristiana Kouta
Christiana Kouta
VRVasilios Raftopoulos
Vasilios Raftopoulos
PYPANAYIOTIS YIALLOUROS
PANAYIOTIS YIALLOUROS
Emerging evidence suggests that vitamin D might be implicated in asthma pathophysiology. This study aims to compare Vitamin D mean serum levels and status between asthmatic and non-asthmatic adolescents and investigate the association of vitamin D with asthma severity. In a cohort of adolescents aged 16–17 years, those reporting wheezing in the past 12 months and Ever asthma on the ISAAC questionnaire were invited to participate and formed the Active Asthmatics group. Controls were selected amongst Never Wheezers/Never Asthmatics (NWNA). Differences in mean 25(OH)D serum levels and vitamin D status between AA and NWNA were examined in multivariate linear and logistic regression models respectively, adjusting for potential confounders. Within AA, differences in vitamin D levels were assessed across asthma severity indicators. A total of 69 AA and 671 NWNA participated in the study. Unadjusted mean 25(OH)D serum levels were 22.90 (SD 6.41), and 21.15 (SD 5.59) ng/mL in NWNA and AA respectively (p = 0.03). In adjusted models, mean 25(OH)D levels remained significantly lower amongst AA compared to NWNA (adjusted beta coefficient −1.68, 95% CI −3.24, −0.13). Severe (<12 ng/mL), moderate (<25 ng/mL) or insufficient (<30 ng/mL) vitamin D status was more prevalent among AA who were 1.6 times (95% CI 1.01, 2.53) more likely to belong to a lower vitamin D category compared to NWNA. Within AA, there was a negative trend between vitamin D levels and the number of reported asthma severity indicators. Levels of vitamin D tend to be lower among asthmatic compared to non-asthmatic children and in those with severe asthma independent of important confounders.

18 May 2011 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
APAnna Papadopoulou
Anna Papadopoulou
MIMichalis Issakidis
Michalis Issakidis
EGEvangelia Gole
Evangelia Gole
KKKonstantina Kosma
Konstantina Kosma
HFHelen Fryssira
Helen Fryssira
SKSophia Kitsiou-Tzeli
Sophia Kitsiou-Tzeli

1 August 2014 in Placenta
Verified
Journal Article
Closed access
APAnna Papadopoulou
Anna Papadopoulou
EGE. Gole
E. Gole
AMA. Moutafi
A. Moutafi
CSC. Sfikas
C. Sfikas
WOW. Oehrl
W. Oehrl
PNP. Nicolaidou
P. Nicolaidou

26 October 2011 in Case Reports in Medicine
Verified
Journal Article
Open access
PDF file
AFAndrew Fretzayas
Andrew Fretzayas
OLOlga Liapi
Olga Liapi
APAnna Papadopoulou
Anna Papadopoulou
PNPolyxeni Nicolaidou
Polyxeni Nicolaidou
ASAlexandra Stamoulakatou
Alexandra Stamoulakatou
Ceftriaxone (cfx), a third-generation cephalosporin antibiotic, leads to transient cholelithiasis in some children, also known as pseudolithiasis. However, the underlying pathogenetic mechanism of this adverse effect has not yet been elucidated. We describe 3 children with ceftriaxone-induced pseudolithiasis, who were also carriers of the A(TA)7TAA polymorphism of theUGT1A1gene, implying that a cause and effect relation may exist.